Role of conflict of interest in scientific objectivity

References

• Brown , M. S. , Dana , S. E. and Goldstein , J. L. 1973 . Regulation of 3‐Hydroxy‐3‐Methylglutaryl Coenzyme A Reductase Activity in Human Fibroblasts by Lipoproteins . Proc. Nat. Acad. Sci. USA , 70 : 2162 – 2166 .
   PubMed Web of Science ®Google Scholar
• Brown , M. S. and Goldstein , J. L. 1974 . Familial Hypercholesterolemia: Defective Binding of Lipoproteins to Cultured Fibroblasts Associated with Impaired Regulation of 3‐Hydroxy‐3‐Methylglutaryl Coenzyme A Reductase Activity . Proc. Nat. Acad. Sci. USA , 71 : 788 – 792 .
   PubMed Web of Science ®Google Scholar
• Brown , M. S. and Goldstein , J. L. 1975 . Familial hypercholesterolemia: Genetic, biochemical, and pa‐thophysiologic considerations . Adv. Int. Med. , 20 : 273
   PubMedGoogle Scholar
• 1985 . Chicago Tribune , October 15
   Google Scholar
• Frederickson , D. S. and Levy , R. I. 1972 . “ Familial hyperlipoproteinemia ” . In The Metabolic Basis of Inherited Disease , 3d ed. , Edited by: Stanbury , J. B. , Wyngaarden , J. B. and Fredrickson , D. S. 545 New York : McGraw‐Hill .
   Google Scholar
• Frederickson , D. S. and Levy , R. I. 1972 . “ Familial hyperlipoproteinemia ” . In The Metabolic Basis of Inherited Disease , 3rd ed. , Edited by: Stanbury , J. B. , Wyngaarden , J. B. and Fredrickson , D. S. 545 New York : McGraw‐Hill .
   Google Scholar
• Goldstein , J. L. and Brown , M. S. 1979 . The LDL receptor locus and the genetics of familial hypercholesterolemia . Ann. Rev. Genet. , 13 : 259
   PubMedGoogle Scholar
• Goldstein , J. L. and Brown , M. S. 1973 . Familial hypercholesterolemia: Identification of a defect in the regulation of 3‐hydroxy‐3‐methylglutaryl coenzyme A reductase activity associated with overproduction of cholesterol . Proc. Natl. Acad. Sci. USA , 70 : 2804
   PubMed Web of Science ®Google Scholar
• Harlan , W. R. Jr. , Graham , J. B. and Estes , E. H. 1966 . Familial hypercholesterolemia: A genetic and metabolic study . Medicine , 45 : 77
   Web of Science ®Google Scholar
• Kodoma , T. , Freeman , M. , Rohrer , L. , Zabrecky , J. , Matsudaira , P. and Krieger , M. 1990 . Type I macrophage scavenger receptor contains ‐helical and collagen‐like coiled coils . Nature , 343 : 531 – 535 .
   PubMedGoogle Scholar
• Khachadurian , A. K. 1964 . The inheritance of essential familial hypercholesterolemia . Am. J. Med. , 37 : 402
   PubMedGoogle Scholar
• Khachadurian , A. K. 1968 . Cholestyramine therapy in patients homozygous for familial hypercholesterolemia (familial hypercholesterolemic xanthomatosis) . J. Atheroscler. Res. , 8 : 177
   PubMedGoogle Scholar
• Khachadurian , A. K. 1969 . Lack of inhibition of hepatic cholesterol synthesis by dietary cholesterol in cases of familial hypercholesterolemia . Lancet , October : 778
   PubMedGoogle Scholar
• Khachadurian , A. K. 1971 . A general review of clinical and laboratory features of familial hypercholesterolemia (Type II hyperbetalipoproteinemia) . Protides Bid. Fluids , 19 : 315
   Google Scholar
• Khachadurian , A. K. 1973 . “Prospects For The Parental Diagnosis of Familial Hypercholesterolemia.” . Leb. Med. J. , 26 : 325 – 329 .
   PubMedGoogle Scholar
• Khachadurian , A. K. and Uthman , S. M. 1973 . Experiences with the homozygous cases of familial hypercholesterolemia. A report of 52 patients . Nutr. Metab. , 15 : 132
   PubMedGoogle Scholar
• Khachadurian , A. K. and Kawahara , F. S. 1974 . “Cholesterol Synthesis by Cultured Fibroblasts: Decreased Feedback Inhibition In Familial Hypercholesterolemia.” . J. Lab. Clin. Med. , 83 : 7 – 15 .
   PubMedGoogle Scholar
• Kwiterovich , P. O. Jr. , Fredrickson , D. S. and Levy , R. I. 1974 . Familial hypercholesterolemia (one form of familial type II hyperlipoproteinemia). A study of its biochemical genetic, and clinical presentation in childhood . J. Clin. Invest. , 53 : 1237
   PubMedGoogle Scholar
• Levy , R. I. , Frederickson , D. S. , Stone , N. G. , Bilheimer , D. W. , Brown , W. V. , Glueck , C. J. , Gotto , A. M. , Herbert , P. N. , Kwiterovich , P. O. , Langer , T. , LaRose , J. , Lux , S. E. , Rider , A. K. , Shulman , R. S. and Slogan , H. R. 1973 . Cholestyramine in type II hyperlipoproteinemia. A double‐blind trial . Ann. Intern. Med. , 79 : 51
   PubMedGoogle Scholar
• Myant , N. B. and Slack , J. 1973 . Type II hyperlipoproteinemia . Clin. Endocrinol. Metabol , 2 : 81
   PubMedGoogle Scholar
• 1989 . National Academy of Science On Being a Scientist , 1 – 19 . Washington, D.C. : published by National Academy Press .
   Google Scholar
• Nevin , N. C. and Slack , J. 1968 . Hyperlipidaemic xanthomatosis II. Mode of inheritance of 55 families with essential hyperlipidaemia and xanthomatosis . J. Med. Genet. , 5 : 9
   PubMedGoogle Scholar
• Schrott , H. G. , Goldstein , J. L. , Hazzard , W. R. , McGoodwin , M. M. and Motulsky , A. G. 1972 . Familial hypercholesterolemia in a large kindred: Evidence for a monogenic mechanism . Ann. Intern. Med. , 76 : 711
   PubMedGoogle Scholar
• Shamoo , A. E. Role of Conflict of Interest in Public Advisory Councils , Fidia Research Foundation Symposium Series in press
   Google Scholar
• Siekevitz , P. 1991 . “Citations and the Tenor of the Time.” . FASEB J. , Feb. 5
   PubMedGoogle Scholar
• Thompson , G. R. and Gotto , A. M. Jr. 1973 . Heal bypass in the treatment of hyperlipoproteinaemia . Lancet , 2 : 35
   PubMedGoogle Scholar
• Yamamoto , A. , Yamamura , T. , Yokoyama , S. , Sudo , H. and Matsuzawa , Y. 1984 . Combined drug therapy— cholestyramine and compactin—for familial hypercholesterolemia . J. Clin. Pharmacol. Ther. Toxicol. , 22 : 493
   PubMed Web of Science ®Google Scholar
• Zuckerman , H. 1977 . Scientific Elite. , 1 – 340 . London : The Free Press .
   Google Scholar